Accumulation of β- and γ-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse

Brain Research

Volumn 1019, Issue 1-2, 2004, Pages 1-9

  Wang, Yu Lai ^a   Takeda, Ayako ^a   Osaka, Hitoshi ^a,b   Hara, Yoko ^a   Furuta, Akiko ^a   Setsuie, Rieko ^a,c   Sun, Ying Jie ^a   Kwon, Jungkee ^a,d   Sato, Yae ^a,c   Sakurai, Mikako ^a,c   Noda, Mami ^c   Yoshikawa, Yasuhiro ^d   Wada, Keiji ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b Japan Science and Technology Agency   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Degenerative disease: other; Disorders of the nervous system; Spheroid; Synuclein; Ubiquitin; UCH L1

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; GAMMA SYNUCLEIN; UBIQUITIN THIOLESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GRACILE AXONAL DYSTROPHY; GRACILE NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MALE; MOUSE; NERVE FIBER DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN LOCALIZATION; SPHEROID CELL;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; ANIMALS; BETA-SYNUCLEIN; GAMMA-SYNUCLEIN; MALE; MEDULLA OBLONGATA; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; SYNUCLEINS; UBIQUITIN THIOLESTERASE;

EID: 4043089794     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.05.023     Document Type: Article

References (44)

1. Aicardi J., Castelein P. Infantile neuroaxonal dystrophy. Brain. 102:1979;727-748
2. Arai N. Grumose or foamy spheroid bodies involving astrocytes in the human brain. Neuropathol. Appl. Neurobiol. 21:1995;238-245
3. Bizzi A., Schaetzle B., Patton A., Gambetti P., Autilio-Gambetti L. Axonal transport of two major components of the ubiquitin system: free ubiquitin and ubiquitin carboxyl-terminal hydrolase PGP 9.5. Brain Res. 548:1991;292-299
4. Buchman V.L., Adu J., Pinon L.G., Ninkina N.N., Davies A.M. Persyn, a member of the synuclein family, influences neurofilament network integrity. Nat. Neurosci. 1:1998;101-103
5. Buchman V.L., Hunter H.J., Pinon L.G., Thompson J., Privalova E.M., Ninkina N.N., Davies A.M. Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. J. Neurosci. 18:1998;9335-9341
6. Farrer M., Kachergus J., Forno L., Lincoln S., Wang D.S., Hulihan M., Maraganore D., Gwinn-Hardy K., Wszolek Z., Dickson D., Langston J.W. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann. Neurol. 55:2004;174-179
7. Galvin J.E., Uryu K., Lee V.M., Trojanowski J.Q. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc. Natl. Acad. Sci. U. S. A. 96:1999;13450-13455
8. Galvin J.E., Giasson B., Hurtig H.I., Lee V.M., Trojanowski J.Q. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Am. J. Pathol. 157:2000;361-368
9. Goedert M., Spillantini M.G. Dewy body diseases and multiple system atrophy as alpha-synucleinopathies. Mol. Psychiatry. 3:1998;462-465
10. Halliday W. The nosology of Hallervorden-spatz disease. J. Neurol. Sci. 134:1995;84-91. (Suppl.)
11. Hashimoto M., Rockenstein E., Mante M., Mallory M., Masliah E. beta-synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron. 32:2001;213-223
12. Ichihara N., Wu J., Chui D.H., Yamazaki K., Wakabayashi T., Kikuchi T. Axonal degeneration promotes abnormal accumulation of amyloid beta-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res. 695:1995;173-178
13. Imai Y., Soda M., Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275:2000;35661-35664
14. Kikuchi T., Mukoyarna M., Yamazaki K., Moriya H. Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse. Acta Neuropathol. (Berl.). 80:1990;145-151
15. Kon Y., Endoh D., Iwanaga T. Expression of protein gene product 9.5, a neuronal ubiquitin C-terminal hydrolase, and its developing change in sertoli cells of mouse testis. Mol. Reprod. Dev. 54:1999;333-341
16. Koo E.H., Sisodia S.S., Archer D.-R., Martin L.J., Weidemarm A., Beyreuther K., Fischer P., Masters C.L., Price D.L. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. U. S. A. 87:1990;1561-1565
17. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108
18. Lavedan C., Leroy E., Dehejia A., Buchholtz S., Dutra A., Nussbaum R.L., Polymeropoulos M.H. Identification, localization and characterization of the human gamma-synuclein gene. Hum. Genet. 103:1998;106-112
19. Liu Y., Fallon L., Lashuel H.A., Liu Z., Lansbury P.T. Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell. 111:2002;209-218
20. Lowe J., McDermott H., Landon M., Mayer R.J., Wilkinson K.D. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J. Pathol. 161:1990;153-160
21. Miura H., Oda K., Endo C., Yamazaki K., Shibasaki H., Kikuchi T. Progressive degeneration of motor nerve terminals in GAD mutant mouse with hereditary sensory axonopathy. Neuropathol. Appl. Neurobiol. 19:1993;41-51
22. Mukoyama M., Yamazaki K., Kikuchi T., Tomita T. Neuropathology of gracile axonal dystrophy (GAD) mouse. An animal model of central distal axonopathy in primary sensory neurons. Acta Neuropathol. (Berl). 79:1989;294-299
23. Nishikawa K., Li H., Kawamura R., Osaka H., Wang Y.L., Hara Y., Hirokawa T., Manago Y., Amano T., Noda M., Aoki S., Wada K. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochem. Biophys. Res. Commun. 304:2003;176-183
24. Osaka H., Wang Y.L., Takada K., Takizawa S., Setsuie R., Li H., Sato Y., Nishikawa K., Sun Y.J., Sakurai M., Harada T., Hara Y., Kimura I., Chiba S., Namikawa K., Kiyama H., Noda M., Aoki S., Wada K. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mel. Genet. 12:2003;1945-1958
25. Oya Y., Nakayasu H., Fujita N., Suzuki K. Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice). Acta Neuropathol. (Berl.). 96:1998;29-40
26. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047
27. Quilty M.C., Gai W.P., Pountney D.L., West A.K., Vickers J.C. Localization of alpha-, beta-, and gamma-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma. Exp. Neurol. 182:2003;195-207
28. Saigoh K., Wang Y.L., Suh J.G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T., Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23:1999;47-51
29. Saito K., Yokoyama T., Okaniwa M., Kamoshita S. Neuropathology of chronic vitamin E deficiency in fatal familial intrahepatic cholestasis. Acta Neuropathol. (Berl). 58:1982;187-192
30. Sampathu D.M., Giasson B.I., Pawlyk A.C., Trojanowski J.Q., Lee V.M. Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies. Am. J. Pathol. 163:2003;91-100
31. Schultz C., Dick E.J., Cox A.B., Hubbard G.B., Braak E., Braak H. Expression of stress proteins alpha B-crystallin, ubiquitin, and hsp27 in pallido-nigral spheroids of aged rhesus monkeys. Neurobiol. Aging. 22:2001;677-682
32. Sidman R., Angevine J.B., Pierce E.T. Atlas of the Mouse Brain and Spinal Cord. 1971;Harvard Univ. Press, Cambridge
33. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science. 302:2003;841
34. H.M. Synder, K. Mensah, I. Surgucheva, B. Festoff, A. Matouschek, A. Surguchov, B. Wolozin, Effect of alpha, beta and gamma synuclein on the proteasomal pathways: 20S ubiquitin-independent, 26S ubiquitin-indenedent and 26S ubiquintin-dependent. Program No.132.8. Abstract viewer/Itinerary Planner. Society for Neuroscience, Washinton, DC, 2003.
35. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., Masliah E. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am. J. Pathol. 152:1998;367-372
36. Takeda A., Hashimoto M., Mallory M., Sundsumo M., Hansen L., Masliah E. C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders. Acta Neuropathol. (Berl.). 99:2000;296-304
37. Tu P.H., Galvin J.E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J.Q., Lee V.M. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol. 44:1998;415-422
38. Wilkinson K.D., Deshpande S., Larsen C.N. Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases. Biochem. Soc. Trans. 20:1992;631-637
39. Willwohl D., Kettner M., Braak H., Hubbard G.B., Dick E.J. Jr., Cox A.B., Schultz C. Pallido-nigral spheroids in nonhuman primates: accumulation of heat shock proteins in astroglial processes. Acta Neuropathol. (Berl). 103:2002;276-280
40. Wu J., Ichihara N., Chui D.H., Yamazaki K., Kikuchi T. Abnormal ubiquitination of dystrophic axons in centralnervous system of gracile axonal dystrophy (gad) mutant mouse. Alzheimer's Res. 47:1996;163-168
41. Yamada T., Akiyama H., McGeer P.L. Two types of spheroid bodies in the nigral neurons in Parkinson's disease. Can. J. Neurol. Sci. 18:1991;287-294
42. Yamazaki K., Wakasugi N., Tomita T., Kikuchi T., Mukoyama M., Ando K. Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse. Proc. Soc. Exp. Biol. Med. 187:1988;209-215
43. Yamazaki K., Moriya H., Wakabayashi T., Kikuchi T. Substance β-like immunoreactivity in the gracile nucleus and fasciculus in old mice. Neurosci. Lett. 106:1989;258-260
44. Yamazaki K., Kobayashi A., Kumazawa A., Wakabayashi T., Takeki K. Axonal degeneration in the central nervous system of gracile axonal dystroph (gad) mice progresses like in human spinocerebellar ataxias. Biomed. Res. 12:1991;143-148